Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Metastatic Non-Small Cell Lung Cancer
Clinical trial register · Taiwan

Metastatic Non-Small Cell Lung Cancer Trials in Taiwan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Taiwan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2875 matching records held by the registry are in this view. Synced 31 Oct 2026, 03:19 UTC
2875
Studies in scope
all four open statuses
1576
Recruiting now
open to new participants
341
Lead sponsors
across recruiting studies
Top sites
Taichung 1 Tainan 1 Taipei 1 Taoyuan 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Daiichi Sankyo3 AstraZeneca2 ArriVent BioPharma, Inc.2 Mirati Therapeutics Inc.1 Merck Sharp & Dohme LLC1 Clear sponsor filter
Site location
Taichung1 Tainan1 Taipei1 Taoyuan1
All 4 locations
Target enrolment
to

Metastatic Non-Small Cell Lung Cancer trials in Taiwan

1 of 2875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Taiwan
Start
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Taichung, Tainan, Taipei, Taoyuan
2020-12-02
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Taiwanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 31 October 2026. https://priyalifescience.com/clinical-trials-taiwan/condition/metastatic-non-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Taiwan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,875 studies in total at the last sync on 31 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies listing the condition Metastatic Non-Small Cell Lung Cancer that also match the filters currently applied.

How many Metastatic Non-Small Cell Lung Cancer trials are recruiting in Taiwan?

1 of the 1 studies on this page are recruiting new participants as of the 31 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Metastatic Non-Small Cell Lung Cancer), 1 studies
PhaseStudiesRecruitingShare
Phase 2/311100%

Most active sponsors

Lead sponsors with the most studies (Metastatic Non-Small Cell Lung Cancer)
Lead sponsorStudiesRecruiting
Mirati Therapeutics Inc.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.